Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) |
| BNF code | 0406000S0AAAKAK |
| Virtual Medicinal Product | Ondansetron 4mg orodispersible tablets |
| Name | Ondansetron 4mg orodispersible tablets |
| Supplier | Sigma Pharmaceuticals Plc |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Oral |
| Actual Medicinal Product Packs | |
| Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) 10 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_12.3.0_20241223000001, imported on 24th December 2024 at 03:51:32.